Management
Dr Dan Gooding, CEO
Dr Gooding has over 10 years experience in commercialisation and business development within the pharmaceutical industry. Dr Gooding began his career in commercial roles with excipients companies such as FMC and Dow Corning. At Accelrys Dr Gooding was responsible for sales across Europe driving new business within nanotechnology, drug delivery and formulation sectors. Dr Gooding has also led successful licensing deals within the pharmaceutical industry with companies such as Johnson & Johnson and AstraZeneca. Dr Gooding is a cofounder of Nuformix.
Dr Joanne Holland, CTO
Dr Holland received her PhD in Chemistry from Leeds University. She joined the process R&D group at Millennium Pharmaceuticals before moving to a combined research and commercial role at Stylacats Ltd. After this Dr Holland worked for Medeor Pharma Ltd and Medeor Ltd undertaking commercial and scientific research on new business and investment opportunities. Dr Holland is a cofounder of Nuformix, and is responsible for R&D, intellectual property and regulatory issues.
Neville Hamlin, CFO
Mr Hamlin holds board directorships and company secretary positions for the CPI groups of companies. A professional qualified chartered accountant with an MBA, he has over 20 years experience in senior management and board positions, setting up the Siemens UK Microelectronics facility in 1995 and Atmel’s UK manufacturing site in 2000. Mr Hamlin has also established key start-ups, co-founding a biofuels company in its development towards AIM listing and has also been involved in several MBOs/MBIs. Mr Hamlin possesses a broad knowledge of financial engineering as applied to both corporate and start-up businesses.